<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287816</url>
  </required_header>
  <id_info>
    <org_study_id>2019H0504-A</org_study_id>
    <nct_id>NCT04287816</nct_id>
  </id_info>
  <brief_title>Achieving Nutritional Adequacy Of Vitamins E and K With An Egg/Plant-Based Food Pairing - Study 1</brief_title>
  <official_title>Achieving Nutritional Adequacy Of Vitamins E and K With An Egg/Plant-Based Food Pairing - Study 1</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Malnutrition of the fat-soluble nutrients vitamin E (α-tocopherol; αT) and vitamin K
      (phylloquinone; PQ) is problematic. Since αT and PQ are rich in plant foods (e.g. spinach)
      that are mostly absent of accessible lipid, dietary patterns that can potentiate αT and PQ
      bioavailability by pairing vegetables with lipid-rich foods have been emphasized. The purpose
      of this study is to use deuterium-labeled spinach (containing stable isotopes of αT and PQ)
      to validate eggs as a dietary tool to improve αT and PQ bioavailability directly from a model
      plant food, and hence achieve nutrient adequacy. It is expected that compared with
      deuterium-labeled spinach alone, co-ingestion of eggs will dose-dependently increase plasma
      bioavailability of spinach-derived deuterium-labeled αT and PQ without affecting time to
      maximal concentrations or half-lives. The outcome will therefore support an egg-based food
      pairing that can enhance the health benefits of plant-centric dietary patterns.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the US, 92-96% and 43-63% of men and women do not meet recommended intakes for αT and PQ,
      respectively. Dietary recommendations strongly encourage a diet rich in fruits and vegetables
      to meet dietary αT and PQ requirements. However, αT and PQ bioavailability from most plant
      foods is quite poor, thereby emphasizing a need for effective food pairings that can enhance
      the absorption and promote adequate status of these health-promoting nutrients. The objective
      of this application is to use deuterium-labeled spinach (containing stable isotopes of αT and
      PQ) to validate eggs as a dietary tool to improve αT and PQ bioavailability directly from a
      model plant food, and hence achieve nutrient adequacy. Our hypothesis is that the
      bioavailability of αT and PQ from deuterium-labeled spinach will be potentiated by egg intake
      in a dose-dependent manner by increasing their secretion in intestinal-derived chylomicrons.

      To test this, our specific aim is to assess egg-mediated improvements in αT and PQ
      bioavailability by conducting a pharmacokinetic study in healthy men and women. Participants
      will ingest deuterium-labeled spinach (containing 2 mg αT and 500 μg PQ) with 0, 1, 2, or 3
      hardboiled eggs (containing 0, 4.8, 9.6, or 14.4 g total fat) in a randomized cross-over
      design. Eucaloric diets will be controlled for αT and PQ intakes for 3 d prior to and during
      the initial 24 h of each trial to minimize heterogeneity of pharmacokinetic responses.
      Spinach-derived deuterium-labeled αT and PQ will be measured in plasma and isolated
      chylomicrons collected at timed intervals from 0-72 h post-meal ingestion, and biomarkers of
      antioxidant status and oxidative distress will be assessed at baseline (0 h) of each trial.
      Outcomes from this study are expected to demonstrate a dose-dependent function of eggs to
      increase deuterium-labeled αT and PQ bioavailability (based on AUC0-72 h, Cmax, and %
      estimated absorption) without affecting time to maximal concentrations or half-lives.

      The rationale for this study is that, by establishing the efficacy of eggs to potentiate
      plant-derived fat-soluble nutrient bioavailability, a strong framework will exist for an
      easily implementable health-promoting food pairing strategy to overcome malnutrition of αT
      and PQ.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin E Bioavailability</measure>
    <time_frame>0, 3, 6, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach</time_frame>
    <description>Area under the curve of deuterium-labeled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin E Cmax</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Maximum plasma concentration of deuterium-labeled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Absorption (%Dose) of Vitamin E</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Absorption of deuterium-labeled alpha-tocopherol</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin K Bioavailability</measure>
    <time_frame>0, 3, 6, 9, 12, 24, 36, 48, 72 hours post-ingestion of spinach</time_frame>
    <description>Area under the curve of deuterium-labeled phylloquinone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Vitamin K Cmax</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Maximum plasma concentration of deuterium-labeled phylloquinone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Estimated Absorption (%Dose) of Vitamin K</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Absorption of deuterium-labeled phylloquinone</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vitamin E Tmax</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Time to reach maximum plasma concentration of deuterium-labeled alpha-tocopherol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chylomicron Vitamin E</measure>
    <time_frame>0, 3, 6, 9, 12 hours post-ingestion of spinach</time_frame>
    <description>Deuterium-labeled alpha-tocopherol concentration in chylomicron</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination Rate of Vitamin E</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Rate of plasma elimination of deuterium-labeled alpha-tocopherol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin K Tmax</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Time to reach maximum plasma concentration of deuterium-labeled phylloquinone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chylomicron Vitamin K</measure>
    <time_frame>0, 3, 6, 9, 12 hours post-ingestion of spinach</time_frame>
    <description>Deuterium-labeled phylloquinone concentration in chylomicron</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Elimination Rate of Vitamin K</measure>
    <time_frame>0-72 hours post-ingestion of spinach</time_frame>
    <description>Rate of plasma elimination of deuterium-labeled phylloquinone</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Vitamin C</measure>
    <time_frame>Prior to (0 hour) spinach consumption</time_frame>
    <description>Baseline plasma vitamin C concentration</description>
  </other_outcome>
  <other_outcome>
    <measure>Malondialdehyde</measure>
    <time_frame>Prior to (0 hour) spinach consumption</time_frame>
    <description>Baseline plasma malondialdehyde concentration</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Nutritional Requirements</condition>
  <arm_group>
    <arm_group_label>Zero hard-boiled egg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>No eggs will be consumed on the test day. Deuterium-labeled spinach containing 2 mg αT and 500 ug PQ will be ingested alone prior to the 72-h pharmacokinetics trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>One hard-boiled egg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deuterium-labeled spinach containing 2 mg αT and 500 ug PQ will be ingested along with 1 hard-boiled egg prior to the 72-h pharmacokinetics trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two hard-boiled eggs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deuterium-labeled spinach containing 2 mg αT and 500 ug PQ will be ingested along with 2 hard-boiled eggs prior to the 72-h pharmacokinetics trial.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Three hard-boiled eggs</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Deuterium-labeled spinach containing 2 mg αT and 500 ug PQ will be ingested along with 3 hard-boiled eggs prior to the 72-h pharmacokinetics trial.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Zero hard-boiled egg</intervention_name>
    <description>No eggs will be consumed on test day</description>
    <arm_group_label>Zero hard-boiled egg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>One hard-boiled egg</intervention_name>
    <description>One egg will be consumed on test day</description>
    <arm_group_label>One hard-boiled egg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Two hard-boiled eggs</intervention_name>
    <description>Two eggs will be consumed on test day</description>
    <arm_group_label>Two hard-boiled eggs</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Three hard-boiled eggs</intervention_name>
    <description>Three eggs will be consumed on test day</description>
    <arm_group_label>Three hard-boiled eggs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body Mass Index (BMI) = 19-25 kg/m2

          -  Normolipidemic (total cholesterol &lt;240 mg/dL; triglyceride &lt;150 mg/dL)

          -  Fasting glucose &lt;100 mg/dL

          -  No use of dietary supplements for &gt;1 month

          -  No use of medications that affect lipid or glucose metabolism

          -  Non-smoker

          -  No history of gastrointestinal disorders

        Exclusion Criteria:

          -  Egg allergy

          -  Alcohol intake &gt; 2 drinks per day

          -  Aerobic activity &gt;7 h/wk

          -  Body mass change &gt;2 kg in the past 1 month

          -  Women who are pregnant, lactating, or initiated or changed birth control in the past 3
             month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard S Bruno, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard S Bruno, Ph.D.</last_name>
    <phone>614-292-5522</phone>
    <email>bruno.27@osu.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Richard S Bruno, Ph.D.</last_name>
      <phone>614-292-5522</phone>
      <email>bruno.27@osu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 22, 2020</study_first_submitted>
  <study_first_submitted_qc>February 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Richard Bruno</investigator_full_name>
    <investigator_title>Professor and Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Vitamin E</keyword>
  <keyword>Vitamin K</keyword>
  <keyword>Egg</keyword>
  <keyword>Spinach</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

